Latin America Adme Toxicology Testing Market Size & Outlook
Latin America adme toxicology testing market, 2018-2030 (US$M)
Latin America adme toxicology testing market highlights
- The Latin America adme toxicology testing market generated a revenue of USD 453.4 million in 2023.
- The market is expected to grow at a CAGR of 8% from 2024 to 2030.
- In terms of segment, cell culture tech was the largest revenue generating technology in 2023.
- Cell Culture Tech is the most lucrative technology segment registering the fastest growth during the forecast period.
Latin America data book summary
| Market revenue in 2023 | USD 453.4 million |
| Market revenue in 2030 | USD 775.9 million |
| Growth rate | 8% (CAGR from 2023 to 2030) |
| Largest segment | Cell culture tech |
| Fastest growing segment | Cell Culture Tech |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Cell Culture Tech |
| Key market players worldwide | Thermo Fisher Scientific Inc, Promega, Agilent Technologies Inc, Curia, Dassault Systemes SE, Beckman Coulter, Catalent Inc, Charles River Laboratories International Inc, Labcorp Drug Development, Eurofins Scientific SE, GE HealthCare Technologies Inc Common Stock, Miltenyi Biotec, IQVIA Holdings Inc |
Other key industry trends
- In terms of revenue, Latin America region accounted for 4.7% of the global adme toxicology testing market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 2,831.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
ADME Toxicology Testing Market Scope
ADME Toxicology Testing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Latin America adme toxicology testing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to adme toxicology testing market will help companies and investors design strategic landscapes.
Cell culture tech was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the Latin America adme toxicology testing market based on cell culture tech covering the revenue growth of each sub-segment from 2018 to 2030.
In Latin America, guidelines from International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH) are being adopted by the countries for harmonization of the development and approval of new medicines.
Furthermore, initiatives of the Pan American Health Organization (PAHO) via the Pan American Network for Drug Regulatory Harmonization (PANDRH) enables the LATAM countries to align drug development process across the countries and reinforce harmonization for drug development.
At present, Latin American pharmaceutical market represents significant share in global pharmaceutical sales, thereby driving demand for ADME screening. The development of regional free trade zones in conjunction with harmonization of pharmaceutical regulation is being initiated in the recent times.
Reasons to subscribe to Latin America adme toxicology testing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Latin America adme toxicology testing market databook
-
Our clientele includes a mix of adme toxicology testing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America adme toxicology testing market, including forecasts for subscribers. This continent databook contains high-level insights into Latin America adme toxicology testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Latin America adme toxicology testing market
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
